Back to today’s briefing

Story perspectives

FDA Alerts Patients on New Risks for Common Medications

2/21/2025

26 6

Summary

Story summary

The FDA has issued crucial safety updates for medications like Depakote, Leqembi, and Ozempic, revealing new side effects such as ARIA linked to Leqembi and swallowing difficulties with Xtandi. These revisions in warnings and medication descriptions are designed to prioritize patient safety, ensuring that users are well-informed about potential risks.

1 of 1

Story summary

The FDA has issued crucial safety updates for medications like Depakote, Leqembi, and Ozempic, revealing new side effects such as ARIA linked to Leqembi and swallowing difficulties with Xtandi. These revisions in warnings and medication descriptions are designed to prioritize patient safety, ensuring that users are well-informed about potential risks.